From bench to bedside a comprehensive review of pancreatic cancer immunotherapy
The incidence of pancreatic cancer has been increasing while its 5-year survival rate has not changed in decades. In the era of personalized medicine, immunotherapy has emerged as a promising treatment modality in a variety of malignancies, including pancreatic cancer. This review will discuss the u...
Main Authors: | Kunk, Paul R., Bauer, Todd W., Slingluff, Craig L., Rahma, Osama E. |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791889/ |
Similar Items
-
From Bench to Bedside: Immunotherapy for Prostate Cancer
by: Tse, Brian Wan-Chi, et al.
Published: (2014) -
Small Cell Carcinoma of the Gallbladder: Case Report and Comprehensive Analysis of Published Cases
by: Carrera, Carolyn, et al.
Published: (2015) -
Natural Killer Cell Immunotherapy: From Bench to Bedside
by: Domogala, Anna, et al.
Published: (2015) -
Targeting gamma delta T cells for cancer immunotherapy: bench to bedside
by: Gogoi, Dimpu, et al.
Published: (2013) -
Bench and Bedside
by: Schmidt, Christian
Published: (2002)